Search icon

MOLECULAR INTERNATIONAL RESEARCH, INC.

Company Details

Name: MOLECULAR INTERNATIONAL RESEARCH, INC.
Jurisdiction: New York
Legal type: DOMESTIC BUSINESS CORPORATION
Status: Active
Date of registration: 02 Jan 1997 (28 years ago)
Entity Number: 2097896
ZIP code: 10017
County: New York
Place of Formation: New York
Address: 295 MADISON AVENUE,12TH FLOOR, NEW YORK, NY, United States, 10017
Principal Address: 317 E 53RD ST, NEW YORK, NY, United States, 10022

Shares Details

Shares issued 200

Share Par Value 0

Type NO PAR VALUE

Chief Executive Officer

Name Role Address
SYLVIE BELJANSKI Chief Executive Officer 317 E 53RD ST, NEW YORK, NY, United States, 10022

DOS Process Agent

Name Role Address
KMA LAW, P.C. DOS Process Agent 295 MADISON AVENUE,12TH FLOOR, NEW YORK, NY, United States, 10017

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

CAGE Code:
6SAE3
UEI Expiration Date:
2014-10-23

Business Information

Activation Date:
2013-10-23
Initial Registration Date:
2012-06-20

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
6SAE3
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2024-02-29

Contact Information

POC:
JOHN L. HALL
Phone:
+1 917-609-7065
Fax:
+1 212-593-3925

History

Start date End date Type Value
2025-01-22 2025-01-22 Address 317 E 53RD ST, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer)
2024-03-06 2024-03-06 Address 317 E 53RD ST, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer)
2024-03-06 2025-01-22 Address 317 E 53RD ST, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer)
2024-03-06 2025-01-22 Shares Share type: NO PAR VALUE, Number of shares: 200, Par value: 0
2024-03-06 2025-01-22 Address 295 MADISON AVENUE,12TH FLOOR, NEW YORK, NY, 10017, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
250122003382 2025-01-22 BIENNIAL STATEMENT 2025-01-22
240306003760 2024-03-06 BIENNIAL STATEMENT 2024-03-06
210106060657 2021-01-06 BIENNIAL STATEMENT 2021-01-01
201120000277 2020-11-20 CERTIFICATE OF CHANGE 2020-11-20
190115060672 2019-01-15 BIENNIAL STATEMENT 2019-01-01

Trademarks Section

Serial Number:
77000432
Mark:
PRIMABEL
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
TRADEMARK
Application Filing Date:
2006-09-15
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
PRIMABEL

Goods And Services

For:
Pharmaceutical preparations and substances, namely pharmaceutical preparations for the treatment of cell deficiencies, DNA system modifications and viral infections; pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for skin treatment and appearance; dietary supplement...
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
77000374
Mark:
MIRKIN
Status:
ABANDONED - AFTER INTER-PARTES DECISION
Mark Type:
TRADEMARK
Application Filing Date:
2006-09-15
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
MIRKIN

Goods And Services

For:
Pharmaceutical preparations and substances, namely pharmaceutical preparations for the treatment of cell deficiencies, DNA system modifications and viral infections; pharmaceutical preparations for use in chemotherapy; Dietary supplements
International Classes:
005 - Primary Class
Class Status:
Abandoned

Date of last update: 01 Apr 2025

Sources: New York Secretary of State